Unilever Consumer Care Limited (DSE:UNILEVERCL)
2,176.50
-10.90 (-0.50%)
At close: Jan 22, 2026
Unilever Consumer Care Revenue
Unilever Consumer Care had revenue of 1.01B BDT in the quarter ending September 30, 2025, with 26.01% growth. This brings the company's revenue in the last twelve months to 3.63B, up 4.79% year-over-year. In the year 2024, Unilever Consumer Care had annual revenue of 3.38B, down -14.44%.
Revenue (ttm)
3.63B
Revenue Growth
+4.79%
P/S Ratio
11.55
Revenue / Employee
59.52M
Employees
61
Market Cap
41.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.38B | -570.90M | -14.44% |
| Dec 31, 2023 | 3.95B | -144.37M | -3.52% |
| Dec 31, 2022 | 4.10B | -44.99M | -1.09% |
| Dec 31, 2021 | 4.14B | 674.61M | 19.45% |
| Dec 31, 2020 | 3.47B | -572.80M | -14.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Square Pharmaceuticals PLC. | 80.13B |
| Beximco Pharmaceuticals PLC. | 46.34B |
| Renata | 44.03B |
| The ACME Laboratories | 37.48B |
| The IBN SINA Pharmaceutical Industry | 12.84B |
| Beacon Pharmaceuticals | 11.58B |
| Navana Pharmaceuticals | 9.52B |
| Techno Drugs | 3.23B |